MARKET WIRE NEWS

Fennec Pharmaceuticals Inc. (FENC) Q1 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-05-13 12:23:04 ET

Fennec Pharmaceuticals Inc. (FENC)

Q1 2025 Earnings Conference Call

May 13, 2025 8:30 AM ET

Company Participants

Robert Andrade - Chief Financial Officer

Jeff Hackman - Chief Executive Officer and Director

Conference Call Participants

Chase Knickerbocker - Craig Hallum

Sudan Loganathan - Stevens

Michael Okunewitch - Maxim Group

Raghuram Selvaraju - H.C. Wainwright

Presentation

Operator

Good morning, ladies and gentlemen. And welcome to Fennec Pharmaceuticals First Quarter 2025 Earnings and Corporate Update Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions on how to participate will be given at that time. As a reminder, today's conference call is being recorded....

Read the full article on Seeking Alpha

For further details see:

Fennec Pharmaceuticals Inc. (FENC) Q1 2025 Earnings Call Transcript
Fennec Pharmaceuticals Inc.

NASDAQ: FENC

FENC Trading

15.39% G/L:

$10.12 Last:

170,533 Volume:

$9.29 Open:

mwn-app Ad 300

FENC Latest News

FENC Stock Data

$217,266,422
14,266,721
89.84%
25
N/A
Biotechnology & Life Sciences
Healthcare
US
Research Triangle Park

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App